Overall operative mortality, patency rates, and limb salvage for autologous vein LEB in CLI patients continue to be excellent in the endovascular era and are not necessarily affected by a prior ipsilateral endovascular procedure. Long-term survival remains poor in CLI patients requiring LEB.

OVH and EVH have similar failure mechanisms, limb salvage, amputation-free survival, and overall survival. EVH is associated with impaired patency, increased need for intervention, longer operative times, shorter hospital stays, and decreased vein harvest site wound complications. OVH of the great saphenous vein may provide optimal patency but was not necessarily associated with better patient-centered outcomes. Similar limb salvage rates and amputation-free survival may justify the use of EVH, despite inferior patency, to capture shorter hospital stays and decreased wound complications.

No abstract

No abstract

by claudication, CLI, and aneurysmal disease treated with an Endologix abdominal endograft.Methods: A retrospective review of all endovascular aorto-iliac aneurysms repaired with an Endologix device was perfomed at a single institution between January 2008 and April 2013. This revealed 51 patients who were treated with the Endologix device for aorto-iliac aneurysms who had coexisting aortoiliac occlusive disease. Patient demographics, procedural details, and clinical follow-up were reviewed.Results: All nine (100%) of the patients had claudication and three (33%) had CLI. One patient presented with an aortic rupture and the remaining eight patients were elective. Successful deployment of the endovascular device was achieved in all nine (100%) patients. There was no 30day mortality or reintervention within 1 year. Of the nine patients, three (33%) had complete iliac occlusions which were all crossed utilizing an Outback re-entry device. The remaining six (66%) patients all had iliac stenoses and two (22%) also had aortic stenoses. Preprocedural and postprocedural ABIs were available in 8 of 9 patients. Mean bilateral preprocedure ABI was 0.70 which increased to 0.86 postprocedure.Conclusions: Significant coexisting arterial disease may be encountered in patients with aortic or iliac aneurysms. Identification of coexisting arterial diseases is essential to help tailor treatment for coexisting occlusive and aneurysm disease. The Endologix abdominal endograft has properties that perform well in this patient population in our single-center review.